Keyphrases
A172
32%
Anti-inflammatory Effect
29%
Anti-neuroinflammation
40%
Astrocytes
23%
Astroglia
27%
Astroglial Cells
51%
C57BL
24%
Central Nervous System
21%
Chemokine (C-C motif) Ligand 2 (CCL2)
42%
Chemokine Expression
42%
Chemokines
24%
Colon Adenocarcinoma
28%
CXCL10
98%
Cytotoxicity
22%
Dorsal Vagal Complex
21%
Ethanol
43%
Hippocampus
22%
HT-29
28%
Human Astrocytes
35%
Inducible Nitric Oxide Synthase
57%
Inflammation
41%
Inflammatory Chemokines
21%
Inflammatory Pathways
46%
Interleukin-1β
50%
Interleukin-6
30%
Lipopolysaccharide
62%
Lipopolysaccharide-induced
100%
Liver
30%
Metabolic Hormones
26%
Microglial Cells
22%
Monocyte Chemoattractant protein-1 (MCP-1)
22%
Morphine
20%
Neuroimmune Response
27%
Neuroimmune Signaling
29%
Neuroinflammation
83%
NF-B
51%
Nuclear factor-B
24%
Obesity
25%
Opioid Antagonist
34%
Ovariectomy
38%
OVX Rats
24%
Paraventricular nucleus
23%
Selenite
39%
Sex-specific
21%
Sickness
21%
Sickness Behavior
24%
Social Defeat
28%
Toll-like
52%
Weight Gain
35%
μ-opioid Receptor
20%
Neuroscience
Adeno-Associated Virus
19%
Alternative Complement Pathway C3 C5 Convertase
14%
Alzheimer's Disease
12%
Anti-Inflammatory
31%
Anxiety Disorder
11%
Arcuate Nucleus
26%
Astrocyte
75%
Behavior (Neuroscience)
39%
Blood Plasma
41%
CCL2
30%
Central Nervous System
27%
Cerebellum
16%
Chemokine
54%
CREB
19%
CXCL10
78%
Dentate Gyrus
19%
Duragesic
14%
Fentanyl
14%
Gamma Interferon Inducible Protein 10
26%
Ghrelin
14%
Glial Fibrillary Acidic Protein
18%
Hippocampus
34%
Human Immunodeficiency Virus
15%
In Vitro
12%
In Vivo
16%
Inducible Nitric Oxide Synthase
28%
Interferon
16%
Interleukin 1
33%
Interleukin 6
24%
Leptin
25%
Lipopolysaccharide
92%
Messenger RNA
12%
Microglia
28%
Monocyte Chemotactic Protein 1
14%
Mood Disorder
14%
Morphine
20%
Naltrexone
18%
Narcotic Antagonist
30%
Neurological Disorder
13%
Nitric Oxide Synthase
19%
Nuclear Factor
14%
Opiate
19%
Pervasive Developmental Disorder
11%
Proinflammatory Cytokine
14%
Protein Expression
18%
Receptor
14%
Sickness Behavior
19%
Social Defeat
28%
TLR 4
43%
μ-Opioid Receptor
26%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
15%
Anti-Inflammatory Drug
20%
Antiinflammatory Activity
23%
Antiinflammatory Agent
10%
Aurintricarboxylic Acid
12%
Chemokine
71%
Colon Carcinoma
28%
Cytokine
30%
Cytotoxicity
19%
Disease
59%
Duragesic
15%
Enzyme-Linked Immunosorbent Assay
14%
Gamma Interferon Inducible Protein 10
15%
Glial Fibrillary Acidic Protein
13%
Glutathione
11%
Immunoglobulin Enhancer Binding Protein
17%
Inducible Nitric Oxide Synthase
28%
Inflammation
34%
Interferon
17%
Interleukin 1
20%
Interleukin 6
22%
Leptin
19%
Lipopolysaccharide
68%
Lipopolysaccharide-Induced Inflammation
19%
Lipopolysaccharide-Induced Neuroinflammation
16%
Microtus
10%
Microtus Ochrogaster
14%
Mitogen Activated Protein Kinase P38
9%
Mood Disorder
11%
Morphine
11%
Mu Opiate Receptor Antagonist
13%
Naltrexone
19%
Narcotic Antagonist
22%
Nervous System Inflammation
35%
Neurologic Disease
14%
Neuropathic Pain
14%
Nicotinic Receptor
20%
Nitric Oxide Synthase
9%
Normal Human
12%
Nuclear Factor
17%
Opiate
14%
Positive Allosteric Modulator
28%
Reactive Oxygen Metabolite
16%
Receptor
21%
Sodium Selenite
9%
Superoxide
15%
Toll Like Receptor 4
48%
Tumor Necrosis Factor
34%
Western Blot
10%
μ-Opioid Receptor
13%